Propafenone Facilitates Mitochondrial-Associated Ferroptosis and Synergizes with Immunotherapy in Melanoma

Through large-scale drug screening of cardiovascular drugs, scientists identified propafenone, an anti-arrhythmia medication, as capable of synergizing with ferroptosis inducers in melanoma.